This is the authors' abstract. We don't add key points for this paper.
Like the younger sister of a brilliant, and sometimes aggressive, older T-cell brother, the B cell knows some essential things about survival: that ‘humility is endless’ and it is okay to ask for help,1 and she does. She gets help not only from T cells during adaptive immune responses, but also from many other would-be nurses and factors, including B cell activating factor belonging to the TNF family (BAFF, BLyS): a survival nutrient better than green vegetables. When immature B cells leave the bone marrow (BM) and migrate to the spleen, they need BAFF to become mature follicular or marginal zone B cells.2 At this stage, BAFF is provided by a stromal nurse cell.3 Marginal zone B cells also require BAFF to respond rapidly and produce protective IgM to encapsulated bacteria; in this case, BAFF is produced by dendritic cells (DCs) in response to stimulation via Toll-like receptors.4 A new finding published in Nature Immunology by Sapoznikov et al.5 identifies a novel population of DCs in the BM (bmDCs) that are responsible for maintaining long-lived B cells in this compartment through production of an unexpected green vegetable for B cells, macrophage migratory-inhibition factor (MIF). Dendritic cells play a central role in responding to pathogens and programming adaptive T-cell responses in secondary lymphoid organs such as the spleen and lymph nodes. DCs also interact directly with B cells during primary T-independent and T-dependent immune responses.4, 6, 7 Bone marrow DCs have a different phenotype compared to DCs found in the spleen; they express not only increased levels of F4/80, Gr-1, CD103 and CD115, but also relatively high amounts of major histocompatibility complex class I and II, CD86, CD44 and CD40, suggesting that they have been activated. The reason for their constitutive activation is unknown, but this phenotype suggests that bmDCs, unlike splenic DCs, are not involved in maintaining peripheral T-cell tolerance to self antigens (Ags). Sapoznikov et al.5 made use of an elegant transgenic mouse model that allows conditional ablation of CD11chi DCs through administration of diptheria toxin (CD11c-DTRtg). After DC ablation, mice selectively lost BM B cells with a mature phenotype (B220+IgD+IgM+). The ablation of DCs did not substantially affect the numbers of developing pro-B cells, pre-B cells or immature B cells in the BM, or the numbers of B cells in spleen or lymph nodes, demonstrating a specific role for DCs in the maintenance of recirculating mature BM B cells. Two-photon image analysis of cranial BM in vivo revealed characteristic spindle-shaped DCs in distinct perivascular niches in situ together with adoptively transferred B and T cells, suggesting that direct interactions between the DCs and B cells are required for maintaining mature long-lived B cells in the BM. So, how do bmDCs maintain mature B cells in the BM? Could they provide the mature B cells with chemokines for proper positioning in the BM, just as B cells require chemokines for locating to regions in the spleen and lymph nodes?8 Alternatively, could the bmDCs provide BM B cells with critical survival signals? To test these possibilities, the authors adoptively transferred B cells overexpressing a bcl-2 transgene into the CD11c-DTRtg mice prior to DC ablation. The adoptively transferred bcl-2 transgenic B cells were not affected by DC ablation, demonstrating that bmDCs are not required for mature B cells to home to BM, but more likely provide survival signals to B cells after they arrive. Given the strong preference of mature splenic B cells for BAFF nectar, BAFF was a likely candidate for mediating survival of mature BM B cells.2, 3, 4, 7 The authors tested this by generating mixed BM chimeras using BAFF-deficient and CD11c-DTRtg BM in which treatment with diptheria toxin selectively ablated BAFF-expressing DCs, so the mice contained only BAFF-deficient DCs. Surprisingly, BAFF expression by bmDCs was not required to retain recirculating BM B cells. T cells were also seen in perivascular niches with bmDCs and B cells; however, DC ablation did not affect their numbers, suggesting that bmDCs do not act via T cells to keep mature B cells in the BM. Another survival factor, MIF, turned out to be the rescuer. MIF is a chemokine that activates phosphatidylinositol-3-OH kinase-Akt signaling pathways and induces anti-apoptotic signals via binding CD44–CD74 receptor complexes expressed by B cells.9 The BM of MIF-deficient mice contained fewer recirculating mature B cells, and DC ablation in mixed BM chimeras generated with MIF-deficient and CD11c-DTRtg BM produced similar deficiencies in mature BM B-cell numbers as seen in CD11c-DTRtg mice. Importantly, although Sapoznikov et al.5 detected MIF expression by bmDCs, monocytes and macrophages, MIF expression by the latter cells was not sufficient to rescue B-cell homing to BM following DC ablation, directly implicating bmDCs as the critical source of MIF. A number of intriguing questions are raised by these findings. For instance, it is not clear if MIF helps to retain B cells in the BM and/or attract B cells to bmDCs through its chemotactic activity and thereby facilitates cell–cell contact in perivascular niches. Also, it is not clear how MIF production by bmDCs is normally regulated. One interesting possibility is that MIF production by bmDCs is affected by bmDC–B cell interactions. CD22-deficient mice, like DC-deficient mice, lack recirculating BM B cells. DCs in the BM express ligands for CD22, suggesting that direct DC–B cell contact within the BM may be required for B-cell retention.10 The BM can support the differentiation of short-lived plasma cells during primary responses and, indeed, the authors found that IgM plasma cell responses in the BM were decreased in the absence of bmDCs following immunization with the T-independent Ag NP-Ficoll. However, it is not yet certain if bmDCs, like their counterparts in the spleen and blood, directly present T-independent Ags to B cells. The BM is also a chief site of antibody production by long-lived plasma cells generated during T-dependent responses. Maintenance of plasma cells within the BM relies, in part, upon CD44 expression in addition to soluble factors such as interleukin 6 and BAFF.11 Long-lived BM plasma cells also express CD74, and thus may theoretically respond to MIF produced by bmDCs. It is tempting to speculate that bmDCs contribute to the longevity of BM plasma cells through the anti-apoptotic activity of MIF. A picture is beginning to emerge suggesting that B-lineage cells in distinct niches and at different stages have different requirements for their survival. Just like long-lived BM B cells, memory B cells may not require BAFF even though BM plasma cells do.12 In the gut, B cells require a proliferation-inducing ligand (APRIL) produced by a subset of inducible nitric oxide synthase (iNOS)-producing DCs to undergo isotype class switch recombination.13 Somehow B cells find a way to get attention, whether it is BAFF from splenic DCs, APRIL from gut DCs or MIF from bmDCs. They are ‘high-maintenance’ cells, which can get cranky and downright nasty as we age. Too much accessory cell attention may contribute to more aggressive non-Hodgkin's B-cell lymphomas.14 The more we know about how to keep B cells happy, so they can ‘be still and still moving /Into another intensity’,1 the better our chances will be to prevent them from becoming cancerous or autoreactive.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chappell et al. (2008) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: